| 产品详情 |
| Edit |   |
|---|
| Product Name | VHL protein (beta-domain), 1-154aa, Human, His tag, E Coli |
|---|
| Description | MW: 19.2 kDa (174 aa), confirmed by MALDI-TOF. Purity >95% by SDS-PAGE. Von Hippel-Lindau disease (VHL) is a dominant inherited syndrome characterized by the predisposition to develop various kinds of benign and malignant tumors, including clear cell renal carcinomas, pheochromocytomas and hemangioblastomas of the central nervous system and retina. VHL syndrome is caused by germline mutation in the VHL tumor suppressor, and VHL tumors are associated with loss or mutation of the remaining wild-ty |
|---|
| Size | 0.1 mg, 0.5 mg |
|---|
| Concentration | 1 mg/ml (determined by Bradford assay) |
|---|
| Applications | SDS-PAGE |
|---|
| Other Names | [Von Hippel-Lindau tumor suppressor isoform 1; Von Hippel-Lindau tumor suppressor isoform 1; HRCA1; RCA1; VHL1; Von Hippel-Lindau tumor suppressor isoform 1 pVHL; G7 protein; Elongin binding protein; HRCA 1; RCA 1; VHL; VHL 1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor,] |
|---|
| Gene, Accession, CAS # | VHL, Gene ID: 7428, Accession: NP_000542 |
|---|
| Catalog # | MBS203102 |
|---|
| Price | |
|---|
| Order / More Info | VHL protein (beta-domain), 1-154aa, Human, His tag, E Coli from MYBIOSOURCE INC. |
|---|
| Product Specific References | Latif F., et al. (1993) Science. 260 (5112):1317-20; Duan DR., et al. (1995) PNAS. 92 (14):6459-63; Maxwell PH., et al. (1999) Nature 399 (6733):271-5; |
|---|
| 产品资料 |
|
|